Summary. The effect of peroxidative stress on tissue was studied by exposure of red blood cells (RBC) from patients with abetalipoproteinemia to minute amounts of H202 in vitro. Red blood cells from untreated patients showed a marked sensitivity to H202, as evidenced by hemolysis and lipid peroxidation (peroxidative hemolysis).
Introduction
Lipids extracted from human red blood cells are highly susceptible to autoxidation (2) . The possibility of a comparable lipid alteration occur-* Submitted for publication July 1, 1966 ; accepted November 10, 1966. This investigation was supported by U. S. Public Health Service grants HE-02907, HE-01045, and HE-06481.
A preliminary report was published in abstract form
(1 ring in the intact cell has been suggested by the appearance of substances reactive with 2-thiobarbituric acid when RBC from vitamin E-deficient animals were exposed in vitro to hydrogen peroxide (3) (4) (5) (6) or dialuric acid (3, 7) , or in vivo to hyperbaric oxygen (8) . Indeed, lipid peroxidation has been implicated as a mechanism for some of the manifestations of vitamin E deficiency in experimental animals (3, 4, 7, 9, 10) and man (5, 11, 12) . Recently, Kayden and Silber reported that patients with abetalipoproteinemia (acanthocytosis) were deficient in vitamin E; in fact, the serum tocopherol levels were the lowest reported for man (13) . These patients presented a unique opportunity to investigate lipid oxidation in intact human RBC. Rats with experimental vitamin E deficiency were also studied. Red blood cells were exposed to minute amounts of H202 as a stressing agent; hemolysis and lipid peroxidation (peroxidative hemolysis) resulted. This report is the first description of alterations in the RBC phospholipid fatty acids that characterize peroxidative hemolysis of RBC from patients or experimental animals with vitamin E deficiency. Moreover, evidence suggests that these lipid alterations portend hemolysis.
Methods Each of the four following patients with abetalipoproteinemia has been included in previous investigations: A.V. (13) , a girl born in 1957; and R.B. (13) (14) (15) (16) (17) , M.S. (13, (16) (17) (18) , and R.I. (15, (19) (20) (21) , boys born in 1956, 1954, and 1953 , respectively. Control subjects were healthy males and females between the ages of 20 and 40 who were taking no medication. Vitamin E deficiency was produced in male and female Wistar rats by feeding a "tocopherol-deficient diet" 1 from weaning until the age of 6 months, when this study was performed.
We determined plasma tocopherol levels by a micromethod using the Emmerie-Engle reaction (22) . The autohemolysis test was performed by sterile incubation of defibrinated blood at 370 C for 48 hours essentially as described by Young, Izzo, Altman, and Swisher (13, 23) ; samples were run in duplicate and average values reported.
Exposure of RBC suspensions to H202 vapor. Heparinized2 venous blood was stored between 0 and 40 C for up to 18 hours before the RBC were isolated by centrifugation, washed three times in an equal volume of isotonic saline at room temperature, and studied. A 10% suspension of the washed RBC in isotonic saline-phosphate buffer, pH 7.4 (24) , was prepared; 4.5-ml samples were placed in 25-ml Warburg flasks and exposed to minute amounts of H202 by the method of Cohen and Hochstein (25, 26) . The while the flasks were shaken in a Dubnoff metabolic incubator 90 to 100 times a minute at 37°C. In order to facilitate lipid extraction in later experiments in which phospholipid and fatty acid analyses were performed, we increased the hematocrit of the RBC suspension to between 30 and 40%o. 4 Analysis of the incubation suspension. The per cent hemolysis was calculated from the hemoglobin concentration, which was determined by a cyanomethemoglobin method (26) on the supernatant of the incubation suspension after centrifugation and appropriate dilution. The value for 100% hemolysis was obtained by measurement of hemoglobin concentration in a sample of the RBC suspension lysed in the saline-phosphate buffer diluted to be equivalent to 0.1% saline.
The TBA test was performed on a trichloroacetic acid extract of a sample of the incubation suspension with absorbency measurement at 532 mgi (7) . This test provides an index of lipid peroxidation by determination of the malonylaldehyde released on acid hydrolysis (27, 28) .
Analysis of RBC lipid. Lipids were extracted at room temperature from 3.0 ml of the 10% suspension of RBC. After centrifugation at 3,000 X g and aspiration of the supernatant, about 0.3 ml of packed RBC (or ghosts) remained, and this amount was taken as 1 vol for calculation of the quantity of reagents used. One vol of methanol that contained the antioxidant 2,6-di-tert-butyl 4 methyl phenol (BHT),5, 6 5 mg per 100 ml, and 9 vol of methanol alone were added, mixed, and allowed to stand for 30 minutes. Ten vol of chloroform 7 was added, mixed, and allowed to stand for an additional 30 minutes. 5 "Ionol, CP," a gift from the Shell Chemical Co., New York, N. Y. 6 Approximately one part BHT per 100 parts of total lipid, by weight. This amount of BHT was approximately 10 times more than was necessary to prevent autoxidation of dried lipid extracts of normal human RBC (2) . As a result of our first experiments with RBC from patients with abetalipoproteinemia in which an antioxidant was not employed, we found it necessary to add BHT in order to prevent the artifactual development of large amounts of lipid peroxides in the extract. BHT did not appear to reduce lipid peroxides, specifically hydroperoxides, once they developed. This conclusion was based on studies of cod liver oil during various stages of autoxidation, which showed that the peroxide value, determined by an iodometric method, did not decrease when BHT was added after autoxidation had occurred. Because BHT has a characteristic absorbence in the ultraviolet region of the spectrum (29) , absorbency data were corrected for its presence. 7 Chloroform was purified by distillation in an all glass system and stabilized with methanol 1: 50 (vol/vol).
After centrifugation at 3,000 X g for 5 minutes, the supernatant was collected and 10 vol of chloroform followed by 6 of 0.05 M KCl was added, mixed, and allowed to stand overnight at -250 C. When warmed to room temperature, the phases separated cleanly. The lower phase was collected and evaporated in vacuo at 400 C. Complete exclusion of the upper phase was essential for reproducible ultraviolet light absorbency measurements. The lipid extract was dissolved in 5 vol of chloroform and analyzed the same day. In experiments where the hematocrit of the incubation suspension was between 30 and 40%o, lipids were extracted without prior centrifugation from a 2.0-ml sample that was taken as 1 vol for calculation of the quantity of reagents.
The absorbency at 234 and 268 my of the lipid extract dissolved in methanol provides a convenient index of peroxidation of the RBC lipids (2), as conjugated dienes and conjugated trienes that absorb at these wavelengths, respectively, are intermediates during autoxidation and peroxidation of polyunsaturated fatty acids (30) . The extinctions were expressed in terms of the molar concentration of lipid phosphorus. To determine lipid phosphorus, an adaptation of Marinetti's modification of Bartlett's method was used (31) .
We determined the RBC phospholipid distribution by thin-layer chromatography (TLC) on silica gel HR,8 0.5 mm thick, with the developing solvent chloroformmethanol-glacial acetic acid-water 25: 15: 4: 2 (vol/vol) (32) to which we added BHT at a concentration of 50 mg per 100 ml to prevent autoxidation during chromatography (33) . The spots were made visible in ultraviolet light by spraying with a dichlorofluorescein solution, and the phosphorus content of each spot was analyzed (31) .
To prepare RBC total phospholipid fatty acid methyl esters, we employed TLC of the lipid extract on silica gel HR, 0.5 mm thick, in hexane-diethyl ether-glacial acetic acid 70: 30: 1 (vol/vol) containing BHT at a concentration of 50 mg per 100 ml. The phospholipid, which remained at the origin, was scraped into an ampul, and boron trifluoride-methanol reagent9 was added; the ampul was flushed with nitrogen, sealed, and heated in boiling water for 90 minutes according to the method of Morrison and Smith (34) . Four ml of pentane 10 and 1.0 ml of water were added and mixed, and the fatty acid methyl esters were recovered in the pentane phase. Long chain hydroxy fatty acid methyl esters, if present, were not recovered quantitatively by the single extraction with pentane (34) .
Methyl esters of RBC total lipid fatty acids were prepared without prior lipid extraction as follows: A 1.0-ml sample of the incubation suspension was hydrolyzed in 5.0 ml of aqueous 2 N HCl, which contained 25 ,ug of dl-a-tocopherol 1, 11 and 12 ,ug of BHT, in a sealed tube at 1100 C for 18 hours. The fatty acids were ex- 8 Brinkmann Instruments, Inc., Westbury, N. Y. 9 Applied Science Laboratories, Inc., State College, Pa. 10Distilled in an all glass system over KMnO4 and contained BHT, 5 mg per 100 ml.
11Onemg=1 IU.
tracted with diethyl ether that contained BHT, 5 mg per 100 ml, and the ether extract was dehydrated over Na2SO4-NaHCO3, 4: 1, transferred to an ampul, and evaporated to dryness with a stream of nitrogen. The fatty acids were converted to their methyl ester derivatives by adding 1.0 ml of BFs-methanol reagent and heating the sealed ampul for 30 minutes at 1000 C. The fatty acid methyl esters were extracted from the BFsmethanol with pentane and purified by TLC on silica gel HR with development in benzene (34) that contained BHT, 50 mg per 100 ml.
Gas-liquid chromatography (GLC) was performed with a Barber-Colman instrument, model 5000, equipped with paired 8-foot columns of EGSS-X 8%o on Gaschrom P, 100/120 mesh,9 and dual flame ionization detectors. The nitrogen flow rate was 50 ml per minute at the inlet. The column temperature was maintained at 1650 C for 10 minutes after injection of the sample, then increased at 2°C per minute to 2000 C. Thirty-eight peaks were observed and identified on isothermal runs at 1850 C by use of a semilogarithmic plot of retention time data and calculation of type I and type II separation factors according to Ackman and Burgher (35) . Known fatty acid methyl ester mixtures (NHI-type mixtures KB, KD, and KF, and mixtures K107, L203, L205, and L207)9 were used as primary reference standards and cod liver oil fatty acid methyl esters as secondary reference standards (36) . Identification was confirmed by GLC of the RBC total phospholipid methyl esters on a less polar column, EGSS-Y 12%,9 at 1900 C, and by GLC of the methyl ester fractions separated according to their degree of unsaturation by TLC of the acetoxymercuri-methoxy derivatives (31, 37) .
Peak areas were calculated by means of a Disc chart integrator. Quantitative results with National Heart Institute fatty acid methyl ester standard mixtures KB, KD, and KF 9 agreed with the stated composition data with a relative error of less than 2% for major components (> 10%o of the mixture) and less than 3.5% for minor components. BHT eluted with a retention time similar to that of methyl myristate (2) . When taken through the BF3-methanol methylation procedure (34), BHT gave rise to an additional peak, which had a retention time similar to that of methyl palmitoleate (2) . Therefore, myristic and palmitoleic acids were not quantified. We recalculated the per cent composition data for RBC samples exposed to H202 by multiplying the value for each fatty acid by the factor that made the per cent of palmitic acid in the exposed sample equal to the per cent in the control sample. Palmitic acid was selected as the reference peak because it is saturated and should be affected relatively less by peroxidation than unsaturated moieties, and because it is a large component and may be accurately quantified. This method of calculation shows the relative changes that occur in the concentration of the individual acids if palmitic acid is assumed to be constant. Should palmitic acid be lost, however, this method for expression of the data would underestimate losses of other fatty acids. The increase in the relative amount of lignoceric acid (24: 0) (Tables III, IV, V) copherol-treated specimen was protected (TBA = 1.3 X 10-8 mole of malonylaldehyde per ml RBC, hemolysis = 107%o), but the glucose-treated specimen had exhibited peroxidative hemolysis (TBA = 7.2 x 10-s8 mole, hemolysis = 84%o). We provided further evidence for the importance of lipid peroxidation in the hemolysis observed on exposure of RBC from patients with abetalipoproteinemia to H202 in vitro by studying the effect of vitamin E therapy in four patients (Table II) . The RBC from two patients, A.V. and R.B., were studied before and during the administration of vitamin E (d-a-tocopheryl polyethyleneglycol succinate) 18 equivalent to 750 mg of a-tocopherol daily by mouth. Protection of the RBC against autohemolysis, but not H202, was noted after 1 week of therapy. After 8 weeks, the RBC were fully protected for at least 7 hours of exposure to H202. Maintenance of this improvement was documented for patient A.V. after 12 weeks of treatment. Two patients, R.I. and M.S., had received vitamin Ein a variety of dosage forms when these tests were first performed. Their RBC gave normal responses to H1202 in this system on incubation for 7 and 10 hours, respectively. Patient M.S. dis-continued vitamin E therapy, and his RBC exhibited sensitivity to H202 when tested several months later; however, at that time his autohemolysis test was not strikingly abnormal.
The fatty acid and phospholipid distribution of the RBC from these patients during vitamin E therapy (38) was similar to that reported previously for untreated patients with abetalipoproteinemia (15, 18, 39) , suggesting that the protective effect of vitamin E in these studies was not due to correction of the abnormal RBC lipid distribution. Vitamin E administered orally in a water-soluble form protected the RBC, even though tocopherol could not be determined in the plasma. This discrepancy may be explained either by increased plasma levels that were still below the useful range of the method employed (< 0.08 mg per 100 ml) or by increased tissue levels not reflected in the plasma because of the absence of beta lipoprotein, where most of the plasma tocopherol is found normally; tissue levels were not determined.
Sequential measurements of lysis and lipid peroxidation during exposure to H120 diffusion were carried out on the RBC of patient M.S., who had not received vitamin E for 6 months. The results from the two experiments done 4 weeks apart (experiments A and B) are shown in Table III t In this abbreviation of the fatty acids, the first two digits state the number of carbon atoms, the third digit states the number of double bonds, and the digit after the omega states the end carbon chain length.
t The fatty acid percentages in these incubated samples were recalculated by means of the factor that made the per cent of palmitic acid equal to its value in the control sample. § The dimethyl acetal was eluted with this peak and accounted for 12% of the area in control samples; this component remained after exposure to H202.
22:1 accounted for 3% of this peak in control samples. ¶ 24:1 accounted for 55% of this peak in control samples. ** 26:0 accounted for 9% of this peak in control samples.
ft Based on the per cent of phosphorus in each spot on thin layer chromatography. Only 80.4% of the lipid phosphorus of the control RBC was obtained in the lipid extract of cells that were exposed to H202. data from experiment A suggest that lipid changes preceded lysis, as 1) the relative amount of arachidonic acid (20: 4co6) was decreased 12%o after 1.5 hours of incubation, although no abnormal hemolysis was evident; and 2) the TBA reaction was increased 58% of the maximal value after 2.5 hours, when hemolysis was only 7%o. The temporal relationship between parameters of lipid peroxidation and hemolysis for experiment A is diagrammed in Figure 2 . In experiment B, lysis had already proceeded too far at 2.8 hours, and the temporal relationship could not be determined.
The distribution of the individual phospholipids was analyzed in experiment B (Table III) Because the decreased extraction of peroxidized phospholipid may influence results of fatty acid analyses of lipid extracts, the fatty acid composition of the total lipid in the incubation suspension was determined without prior extraction. This was accomplished by acid hydrolysis of the RBC suspension, conversion of the fatty acids to methyl esters, and GLC of these derivatives. The results indicated that mainly the polyunsaturated fatty acids were affected by exposure of the RBC to H202 (Table IV) . The decrease of a given fatty acid moiety appeared to be related to the number of double bonds that it contained. The decrease of the peak that contained the polyunsaturated fatty acid 22: 4a6 probably would have been larger if the peak did not also contain a large amount of nervonic acid (24: 1). By this method of analysis, stearic acid (18: 0) was decreased only 7%.
To assess further the role of vitamin E deficiency in the RBC alterations observed, the RBC from vitamin E-deficient rats were tested in the same manner. The RBC changes that occurred (Table V) were similar to those seen with RBC HCl hydrolysis of the incubation suspension followed by methylation of the extracted fatty acids (see text). Explanation foe abbreviations of the fatty acids is given in footnote to Table III . § The fatty acid percentages in the incubated sample were recalculated to make the per cent of palmitic acid equal to that of the control sample. 30 and 40%, as in the comparable experiments with human RBC (Table III) .
t Explanation for abbreviations of the fatty acids is given in footnote to Table III. t The fatty acid percentages in the incubated sample were recalculated to make the per cent of palmitic acid equal to that of the control sample.
§ Only 90% of the RBC lipid phosphorus in the control sample was obtained in the lipid extract of cells that were exposed to H202. The individual phospholipids were identified only by mobility on the thin layer plate. 1 1 Not positively identified. from the patient with abetalipoproteinemia. Lipid peroxidation again appeared to precede hemolysis; at 0.7 hour the TBA reaction was elevated, but hemolysis was not increased significantly. Considerable hemolysis was evident, however, before H202 exposure, and the hemolysis proceeded at a more rapid rate.
Alpha-tocopherol, when added to the incubation medium before exposure to H202, prevented all of the changes observed in the RBC of patients with abetalipoproteinemia (Tables I and III) and of rats with vitamin E deficiency ( Table V) .
Discussion
The present study demonstrates the striking vulnerability to H202 of RBC from untreated patients with abetalipoproteinemia, as evidenced by lipid peroxidation and hemolysis (peroxidative hemolysis). The lipid peroxidation was similar to that seen in spontaneously autoxidized lipid extracts from normal human RBC (2) . Vitamin E deficiency appeared to be responsible for this vulnerability, as 1) the patients were shown to be deficient in vitamin E, 2) vitamin E is a major biologic lipid antioxidant, 3) administration of vitamin E to the patients or addition to the RBC in vitro prevented peroxidative hemolysis, and 4) the RBC damage in response to H202 could be duplicated in RBC from vitamin E-deficient rats.
Rose and Gyorgy were the first to describe the increased hemolysis of RBC from vitamin E-de- Evidence was obtained supporting a hypothesis that peroxidation of membrane lipids is the basis for hemolysis on exposure to H202 in vitro of RBC from patients with abetalipoproteinemia and vitamin E deficiency. A time sequence study showed a decrease in the relative amount of phospholipid arachidonic acid before abnormal hemolysis occurred and a large increase in the TBA reaction when hemolysis was starting. Similar TBA changes were observed in the RBC from vitamin E-deficient rats. All procedures tested that prevented peroxidation in vitro (i.e., addition to the incubation system of tocopherol, glucose, nitrite, or carbon monoxide) also prevented hemolysis. Finally, after treatment of the patients with vitamin E, their RBC showed increased resistance to H202 in vitro. This effect was presumably due to the antioxidant properties of the vitamin rather than to some possible secondary influence of the vitamin, such as a change in the abnormal distribution of phospholipids and fatty acids in their RBC, because detailed analyses of RBC lipids performed concurrently with this study showed no correction of the altered lipid distribution as a result of treatment with vitamin E (38) .
Heme-containing compounds have been recognized as important catalysts of lipid peroxidation in various animal tissues (9) . Lipid peroxidation in RBC from patients with abetalipoproteinemia appeared to be catalyzed primarily by either oxyor deoxyhemoglobin, because nitrite and carbon monoxide, which produced methemoglobin or carboxyhemoglobin, respectively, inhibited peroxidation. These findings were in agreement with those of Goldstein and Cohen on RBC from vitamin E-deficient rats (6) .
The partial protection of RBC from patients with abetalipoproteinemia by addition of glucose to the incubation suspension may be explained by the action of glutathione peroxidase, which catalyzes the destruction of H202 after it diffuses into the cell (24) . In the absence of glucose, the protective glutathione is lost by oxidation; in the presence of glucose, the NADPH required for reduction of oxidized glutathione is derived from hexose monophosphate shunt activity. Tocopherol, however, protected for a longer incubation time than glucose, in agreement with similar observations with RBC from vitamin E-deficient rats (6) . These findings indicate that tocopherol provides a primary biologic defense against peroxidative hemolysis.
Anemia is not generally found in patients with abetalipoproteinemia; however, Simon and Ways (16) (47, 48) , may be responsible. Aspirin, phenacetin, and sulfonamides are examples of other drugs that have, in theory, this same capability (47) . In addition, exposure of vitamin E-deficient animals to hyperbaric oxygen causes a hemolytic response (4), which appears from recent evidence to be based on peroxidation of membrane lipids (8) . Therefore, treatment of patients with abetalipoproteinemia with H209-producing drugs or hyperbaric oxygen should be approached with caution.
Should peroxidative changes occur in the lipids of RBC in vivo, the clinical manifestations may be tempered by that cell's considerable capacity for replacement. In contrast, the nervous system exhibits greater functional differentiation with limited regenerative capacity and has low levels of the protective enzymes glutathione peroxidase and catalase (55) . Lipid peroxidation of this tissue may be expected to produce diverse and cumulative changes. Indeed, vitamin E deficiency in laboratory animals is associated with characteristic neurological and neuropathological finding (56) (57) (58) . A major disability in abetalipoproteinemia is a progressive neurologic disorder (52, 59) . The possibility arises, therefore, that the neurologic as well as other clinical manifestations in patients with abetalipoproteinemia may result from lipid peroxidation.
